PULMONARY HYPERTENSION
Clinical trials for PULMONARY HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new PULMONARY HYPERTENSION trials appear
Sign up with your email to follow new studies for PULMONARY HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
COPD-Linked lung pressure study halted early
Disease control TerminatedThis study looked at the safety of continuing an inhaled medication called treprostinil in people who have both COPD and high blood pressure in the lungs (pulmonary hypertension). It included 41 adults who had already completed a previous study. The goal was to see if long-term u…
Matched conditions: PULMONARY HYPERTENSION
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated May 26, 2026 07:57 UTC
-
Heart failure drug study halted early after only 4 patients
Disease control TerminatedThis early-stage study tested a new drug called HS135 in obese people with both heart failure (with preserved pumping ability) and high blood pressure in the lungs. The trial was stopped early after enrolling only 4 participants, so no conclusions can be drawn about safety or eff…
Matched conditions: PULMONARY HYPERTENSION
Phase: PHASE1 • Sponsor: 35Pharma Inc • Aim: Disease control
Last updated May 26, 2026 07:56 UTC
-
Xenon MRI sheds light on hidden lung damage in hypertension patients
Knowledge-focused TerminatedThis study aimed to see if a special type of MRI, using xenon gas, could detect changes in the lungs of people with pulmonary hypertension (high blood pressure in the lungs). Researchers looked at how these MRI signals relate to disease severity and progression. The study involve…
Matched conditions: PULMONARY HYPERTENSION
Phase: PHASE2 • Sponsor: Bastiaan Driehuys • Aim: Knowledge-focused
Last updated May 18, 2026 12:00 UTC